Difference in the risk factors for coronary, renal and other peripheral arteriosclerosis in heterozygous familial hypercholesterolemia

Circulation Journal

Volumn 68, Issue 7, 2004, Pages 623-627

  Yagi, Kunimasa ^a   Hifumi, Senshu ^b   Nohara, Atushi ^a   Higashikata, Toshinori ^a   Inazu, Akihiro ^a   Mizuno, Kiyo O ^c   Namura, Masanobu ^d   Ueda, Kosei ^e   Kobayashi, Junji ^a   Shimizu, Masami ^a   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b Hokuriku Central Hospital   (Japan)

^c Fukui Cardiovascular Center   (Japan)

^d KANAZAWA CARDIOVASCULAR HOSPITAL   (Japan)

^e Komatsu Municipal Hospital   (Japan)

Author keywords

Abdominal aortic sclerosis; Coronary artery disease; Familial hypercholesterolemia; Iliac arteriosclerosis; Renal arteriosclerosis

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ABDOMINAL AORTIC SCLEROSIS; ADULT; AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOSITY; HUMAN; ILIAC ARTERIOSCLEROSIS; JAPAN; MAJOR CLINICAL STUDY; MALE; NEPHROSCLEROSIS; RISK FACTOR;

ARTERIOSCLEROSIS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETIC ANGIOPATHIES; FEMALE; HETEROZYGOTE DETECTION; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 3142626464     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.68.623     Document Type: Article

References (31)

1. Staels B. Cardiovascular biology: A cholesterol tether. Nature 2002; 417: 699-701.
2. Wittekoek ME, de Groot E, Prins MH, Trip MD, Buller HR, Kastelein JJ. Differences in intima-media thickness in the carotid and femoral arteries in familial hypercholesterolemic heterozygotes with and without clinical manifestations of cardiovascular disease. Atherosclerosis 1999; 146: 271-279.
3. Kolodgie FD, Katocs AS Jr, Largis EE, Wrenn SM, Cornhill JF, Herderick EE, et al. Hypercholesterolemia in the rabbit induced by feeding graded amounts of low-level cholesterol: Methodological considerations regarding individual variability in response to dietary cholesterol and development of lesion type. Arterioscler Thromb Vasc Biol 1996; 16: 1454-1464.
4. Schrott HG, Goldstein JL, Hazzard WR, McGoodwin MM, Motulsky AG. Familial hypercholesterolemia in a large indred: Evidence for a monogenic mechanism. Ann Intern Med 1972; 76: 711-720.
5. Goldstein JL, Brown MS. Familial hypercholesterolemia: A genetic receptor disease. Hosp Pract (Off Ed) 1985; 20: 35-41, 45-46.
6. Mabuchi H, Miyamoto S, Ueda K, Oota M, Takegoshi T, Wakasugi T, et al. Causes of death in patients with familial hypercholesterolemia. Atherosclerosis 1986; 61: 1-6.
7. Mabuchi H, Tatami R, Haba T, Ueda K, Ueda R, Ito S, et al. Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia. Metabolism 1978; 27: 1672-1679.
8. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1985; 727: 1-113.
9. Tatami R, Mabuchi H, Ueda K, Ueda R, Haba T, Kametani T, et al. Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 1981; 64: 1174-1184.
10. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51(Suppl 4): 5-40.
11. Mabuchi H, Tatami R, Ueda K, Ueda R, Haba T, Kametani T, et al. Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia. Atherosclerosis 1979; 32: 435-444.
12. Dobmeyer J, Lohrmann J, Feussner G. Prevalence and association of atherosclerosis at three different arterial sites in patients with type III hyperlipoproteinemia. Atherosclerosis 1996; 119: 89-98.
13. Sprecher DL, Schaefer EJ, Kent KM, Gregg RE, Zech LA, Hoeg JM, et al. Cardiovascular features of homozygous familial hypercholesterolemia: Analysis of 16 patients. Am J Cardiol 1984; 54: 20-30.
14. Goldstein JL, Kita T, Brown MS. Defective lipoprotein receptors and atherosclerosis: Lessons from an animal counterpart of familial hypercholesterolemia. N Engl J Med 1983; 309: 288-296.
15. Kita Y, Shimizu M, Sugihara N, Shimizu K, Miura M, Koizumi J, et al. Abdominal aortic aneurysms in familial hypercholesterolemia: Case reports. Angiology 1993; 44: 491-499.
16. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
17. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-1307.
18. Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al the ASCOT investigators. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet 2003; 361: 1149-1158.
19. Collins R, Armitage J, Parish S, Sleight P, Peto R, Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet 2004; 363: 757-767.
20. Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, et al J-LIT Study Group. Japan Lipid Intervention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002; 66: 1087-1095.
21. Mabuchi H, Kita T, Matsuzaki M, Matsuzawa Y, Nakaya N, Oikawa S, et al J-LIT Study Group. Japan Lipid Intervention Trial: Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia and coronary heart disease: Secondary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT). Circ J 2002; 66: 1096-1100.
22. Naiki T, Sugiyama H, Tashiro R, Karino T. Flow-dependent concentration polarization of plasma proteins at the luminal surface of a cultured endothelial cell monolayer. Biorheology 1999; 36: 225-241.
23. Hochleitner BW, Hochleitner EO, Obrist P, Eberl T, Amberger A, Xu Q, et al. Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler Thromb Vasc Biol 2000; 20: 617-623.
24. Skalen K, Gustafsson M, Rydberg EK, Hulten LM, Wiklund O, Innerarity TL, et al. Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature 2002; 417: 750-754.
25. Kraft HG, Lingenhel A, Kochl S, Hoppichler F, Kronenberg F, Abe A, et al. Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 1996; 16: 713-719.
26. Kraft HG, Lingenhel A, Raal FJ, Hohenegger M, Utermann G. Lipoprotein(a) in homozygous familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2000; 20: 522-528.
27. Rubba P, Faccenda F, Pauciullo P, Carbone L, Mancini M, Strisciuglio P, et al. Early signs of vascular disease in homocystinuria: A noninvasive study by ultrasound methods in eight families with cystathionine-beta-synthase deficiency. Metabolism 1990; 39: 1191-1195.
28. Kawashiri M, Kajinami K, Nohara A, Yagi K, Inazu A, Koizumi J, et al. Effect of common methylenetetrahydrofolate reductase gene mutation on coronary artery disease in familial hypercholesterolemia. Am J Cardiol 2000; 86: 840-845.
29. Klezovitch O, Edelstein C, Zhu L, Scanu AM. Apolipoprotein(a) binds via its C-terminal domain to the protein core of the proteoglycan decorin: Implications for the retention of lipoprotein(a) in atherosclerotic lesions. J Biol Chem 1998; 273: 23856-23865.
30. Yamamoto M, Hara H, Adachi T. Effects of homocysteine on the binding of extracellular-superoxide dismutase to the endothelial cell surface. FEBS Lett 2000; 486: 159-162.
31. Taira K, Bujo H, Kobayashi J, Takahashi K, Miyazaki A, Saito Y. Positive family history for coronary heart disease and 'midband lipoproteins' are potential risk factors of carotid atherosclerosis in familial hypercholesterolemia. Atherosclerosis 2002; 160: 391-397.